Metformin Plus Sorafenib for Advanced HCC

Clinical trial NCT02672488 · UNKNOWN

Trial details

NCT number: NCT02672488
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2015-12-01
Primary completion: 2017-12-01
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.